Diabetic Neuropathy | Epidemiology | Asia Pacific

Publish date: July 2018

Login to access report

DRG Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of diabetic neuropathy for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered.

DRG Epidemiology’s diabetic neuropathy forecast will answer the following questions:

  • How many people, in each of the major mature pharmaceutical markets have diabetic neuropathy?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of diabetic neuropathy over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.

Note: Coverage may vary by country.

Table of contents

  • Asia Pacific
    • Introduction
      • Key Findings
        • Key Findings
        • Prevalence of Diabetic Neuropathy per 1,000 Among People Aged 20+ in 2018 and 2028
        • Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Diabetic Neuropathy over the Next Ten Years
    • Epidemiology Data
    • Methods
      • Total Prevalent Cases of Diabetic Neuropathy
    • Reference Materials
      • Literature Review
      • Risk/Protective Factors
      • Bibliography

Author(s): Abey John, MPH

Abey John is a medical graduate with a Master’s in Public Health and has been associated with DRG since September 2015. He works with a global team of epidemiologists in performing systematic reviews of assigned diseases and prepare forecast models for clients. He also is involved in producing analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets and have an overall experience of three years working in different healthcare sectors across the country. Prior to joining DRG, Abey had been working with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing Family Planning Health Programs in India with collaborating with the Government of India. He also has worked with a grassroots level NGO as a health team manager which worked for the benefit of the rural population living in the foothills of the Himalayas.